We have worked on the RCAS vector system for more than 20 years; we began to use HIV-1 vectors as tools to study HIV-1 replication about 3 years ago. The RCAS vectors are used for two different types of experiments: 1) To express genes in cells in culture or in animal models (both chicken and mouse) to study gene function and the role(s) particular genes play in development and/or pathogenesis; and 2) to study viral replication. We have developed (and continue to develop) the RCAS vectors and model systems to study the effects of gene expression on pathogenesis and development; these are all collaborative efforts. We are continuing to use the RCAS system to study viral replication. The vectors are replication competent, grow to high titer, and are safe and easy to use. However, given the importance of HIV-1 in human disease and the wealth of information about the structure and function of the HIV-1 proteins including reverse transcriptase (RT), we want to understand HIV-1 replication. We are attempting to correlate the structure and function of HIV-1 RT with the process of reverse transcription in cells infected with a one-round HIV-1 vector. Using this system, we can monitor several of the important steps in reverse transcription and the specificity of ribonuclease H (RNase H) cleavage. This is an important aspect of our current and future research; fortunately, many of the lessons we have learned in developing the RCAS vectors are useful in planning the HIV-1 vector experiments, and some of the tools we have developed (in particular, the shuttle cassette from the RCAS-derived RSVP vectors) can, with some modifications, be used in the HIV-1 system. We believe that the interactions between HIV-1 RT and the different types of nucleic acid substrates it uses are important for the ability of the enzyme to constrain, bend, and properly position the nucleic acid substrates. In turn, the proper positioning of the nucleic acid substrates is critically important both for polymerase function and accurate RNase H cleavage. As a consequence, we are particularly interested in amino acids that contact the nucleic acid substrates and their roles in reverse transcription. We have used a combined structural, biochemical, and vector-based approach to analyze the importance of amino acids in the RNase H domain that contact the RNA/DNA substrate. We plan to continue this type of approach with amino acids that contact the nucleic acid and in the polymerase domain, and have started to use similar approaches to analyze the polypurine tract (ppt). We also plan to select pseudorevertants (compensatory mutations) for some of the mutations that have interesting in vivo phenotypes. As has already been discussed, whenever we obtain unexpected phenotypes in vivo, we will use biochemical (and, where appropriate, structural) analysis to try to understand the basis of the in vivo data. Corresponds to Hughes Project 2 in the May 2003 site visit report of the HIV Drug Resistance Program

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010482-02
Application #
7058138
Study Section
(RRL)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Dunn, Linda L; Boyer, Paul L; McWilliams, Mary Jane et al. (2015) Mutations in human immunodeficiency virus type 1 reverse transcriptase that make it sensitive to degradation by the viral protease in virions are selected against in patients. Virology 484:127-35
Russ, Pamela L; Gonzalez-Moa, Maria J; Vu, B Christie et al. (2009) North- and south-bicyclo[3.1.0]hexene nucleosides: the effect of ring planarity on anti-HIV activity. ChemMedChem 4:1354-63
Hu, Jingqiong; Ferris, Andrea; Larochelle, Andre et al. (2007) Transduction of rhesus macaque hematopoietic stem and progenitor cells with avian sarcoma and leukosis virus vectors. Hum Gene Ther 18:691-700
Jones, Fatima D; Hughes, Stephen H (2007) In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity. Virology 360:341-9
Ambrose, Zandrea; Julias, John G; Boyer, Paul L et al. (2006) The level of reverse transcriptase (RT) in human immunodeficiency virus type 1 particles affects susceptibility to nonnucleoside RT inhibitors but not to lamivudine. J Virol 80:2578-81
McWilliams, Mary Jane; Julias, John G; Sarafianos, Stefan G et al. (2006) Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization. Virology 348:378-88
Garfinkel, David J; Stefanisko, Karen M; Nyswaner, Katherine M et al. (2006) Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap. J Virol 80:11920-34
Oh, Jangsuk; Chang, Kevin W; Alvord, W Gregory et al. (2006) Alternate polypurine tracts affect rous sarcoma virus integration in vivo. J Virol 80:10281-4
Oh, Jangsuk; Chang, Kevin W; Hughes, Stephen H (2006) Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo. J Virol 80:451-9
Chang, Kevin W; Barsov, Eugene V; Ferris, Andrea L et al. (2005) Mutations of a residue within the polyproline-rich region of Env alter the replication rate and level of cytopathic effects in chimeric avian retroviral vectors. J Virol 79:10258-67

Showing the most recent 10 out of 18 publications